LEVERAGE LONG - DIASORIN Stock

Certificat

2J94S

DE000SV66VV6

Market Closed - Euronext Paris 04:43:25 2024-04-11 EDT
24.74 ^EUR	-1.12%

1 month	-26.83%
3 months	-18.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

DiaSorin receives clearance from US FDA for NxTAG panel	02:12am	AN
DiaSorin S p A : receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2	05-16	PU
Funds move on DiaSorin and Leonardo on the Mib.	05-16	AN
Futures bullish; traders believe in Fed cut	05-16	AN

More news

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	DIASORIN S.P.A.
Issuer	Société Générale
	2J94S
ISIN	DE000SV66VV6
Date issued	2023-06-08
Maturity	Unlimited
Parity	1 : 1
Emission price	50.56 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	56.62 €
Lowest since issue	21.93 €
Spread	0.16 €
Spread %	0.64%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company